Siemens Healthineers AG (LTS:0PMJ) Cash Ratio: 0.21 (As of Jun. 2026) — 31% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0PMJ Siemens Healthineers AG LTS:0PMJ
81 GF Score
Price €39.36
GF Value €50.60
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Cash Ratio?

Siemens Healthineers AG LTS:0PMJ +0.15% 81 Cash Ratio is 0.21 as of Jun. 2026, which is 31% above its 10-year median of 0.16. GuruFocus rates LTS:0PMJ with a GF Score™ of 81/100 and a GF Value™ of €50.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 833 Medical Devices & Instruments companies, Siemens Healthineers AG ranks worse than 82.83% on this metric.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Siemens Healthineers AG's Cash Ratio for the quarter that ended in Jun. 2026 was 0.21.

Siemens Healthineers AG has a Cash Ratio of 0.21. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Siemens Healthineers AG's Cash Ratio or its related term are showing as below:

LTS:0PMJ' s Cash Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.16   Max: 0.26
Current: 0.21

During the past 11 years, Siemens Healthineers AG's highest Cash Ratio was 0.26. The lowest was 0.02. And the median was 0.16.

LTS:0PMJ's Cash Ratio is ranked worse than
82.83% of 833 companies
in the Medical Devices & Instruments industry
Industry Median: 0.96 vs LTS:0PMJ: 0.21

Siemens Healthineers AG  (LTS:0PMJ) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Siemens Healthineers AG Cash Ratio Related Terms


Siemens Healthineers AG Cash Ratio Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG Cash Ratio Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.13 0.18 0.24 0.18

Siemens Healthineers AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.18 0.19 0.18 0.21

LTS:0PMJ vs ABT, SYK, MDT: Cash Ratio Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG Cash Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Cash Ratio falls into.


LTS:0PMJ
81GF Score
Siemens Healthineers AG LTS:0PMJ
Cash Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Siemens Healthineers AG's Cash Ratio for the fiscal year that ended in Sep. 2025 is calculated as:

Cash Ratio (A: Sep. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2248/12644
=0.18

Siemens Healthineers AG's Cash Ratio for the quarter that ended in Jun. 2026 is calculated as:

Cash Ratio (Q: Jun. 2026 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2753/12874
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 0.21 mean?
Siemens Healthineers AG (LTS:0PMJ) has a Cash Ratio of 0.21 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Siemens Healthineers AG and its competitors. This is 31% above median its historical median of 0.16. Over the past decade, Siemens Healthineers AG's Cash Ratio has ranged from 0.02 to 0.26. According to the industry distribution chart, Siemens Healthineers AG ranks #690 out of 833 companies in the Medical Devices & Instruments industry, placing it in the top 82.8%.
Is Siemens Healthineers AG's Cash Ratio too high?
Siemens Healthineers AG's current Cash Ratio of 0.21 is 31% above median its 10-year median of 0.16. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.26. The Medical Devices & Instruments industry median Cash Ratio is 0.96. Siemens Healthineers AG's value of 0.21 is 78.1% below this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #690 out of 833 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Siemens Healthineers AG has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Cash Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #690 out of 833 companies for Cash Ratio. This places Siemens Healthineers AG in the lower half of its industry. The industry median Cash Ratio is 0.96. Siemens Healthineers AG's value of 0.21 is 78.1% below this benchmark. Historically, Siemens Healthineers AG's own Cash Ratio has ranged from 0.02 to 0.26 over the past decade. While the company's 10-year median is 0.16 vs. the industry median of 0.96, Siemens Healthineers AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.96, based on 833 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current Cash Ratio of 0.21 is 78.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current Cash Ratio is 0.21, which is 31% above median its own 10-year median of 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.60, compared to a current price of €39.36 — trading 22.2% below its estimated fair value. The current Cash Ratio is 0.21, which is 31% above median its 10-year median of 0.16 and 78.1% below the Medical Devices & Instruments industry median of 0.96. Siemens Healthineers AG's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Cash Ratio is 0.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €39.36 is trading 22.2% below its estimated GF Value™ of €50.60. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for LTS:0PMJ:

  • Cash Ratio: 0.21 (31% above median its 10-year median of 0.16)
  • GF Value™: €50.60 vs. price of €39.36 (22.2% below fair value)
  • GF Score™: 81/100 with 4 warning signs
  • Industry Position: 78.1% below the Medical Devices & Instruments median (#690 of 833)

No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
81GF Score

Get the complete analysis for LTS:0PMJ

Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.36
Price
€50.60
GF Value